Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard

Toxicology and Applied Pharmacology

Volumn 250, Issue 1, 2011, Pages 10-18

  Sunil, Vasanthi R ^a   Patel, Kinal J ^a   Shen, Jianliang ^a   Reimer, David ^a   Gow, Andrew J ^a   Laskin, Jeffrey D ^b   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

COX 2; CTGF; INOS; Lung function; MMP 9; Nitrogen mustard

Indexed keywords

CHLORMETHINE; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOOXYGENASE 2; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; METHACHOLINE;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CHRONIC DISEASE; CHRONIC LUNG DISEASE; CONNECTIVE TISSUE; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; LUNG STRUCTURE; LUNG TOXICITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TIDAL VOLUME; TISSUE GROWTH; TOXICITY;

ANIMALS; CYCLOOXYGENASE 2; INFLAMMATION MEDIATORS; IRRITANTS; LUNG; MALE; MECHLORETHAMINE; NITRIC OXIDE SYNTHASE TYPE II; RATS;

RATTUS;

EID: 78649632548     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.09.016     Document Type: Article

References (41)

1. Allon N., Amir A., Manisterski E., Rabinovitz I., Dachir S., Kadar T. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicol. Appl. Pharmacol. 2009, 241:154-162.
2. Anderson D.R., Taylor S.L., Fetterer D.P., Holmes W.W. Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury. Toxicology 2009, 263:41-46.
3. Bates J.H., Lauzon A.M. Parenchymal tethering, airway wall stiffness, and the dynamics of bronchoconstriction. J. Appl. Physiol. 2007, 102:1912-1920.
4. Bates J.H., Lutchen K.R. The interface between measurement and modeling of peripheral lung mechanics. Respir. Physiol. Neurobiol. 2005, 148:153-164.
5. Bates J.H., Suki B. Assessment of peripheral lung mechanics. Respir. Physiol. Neurobiol. 2008, 163:54-63.
6. Calvet J.H., Jarreau P.H., Levame M., D'Ortho M.P., Lorino H., Harf A., Macquin-Mavier I. Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J. Appl. Physiol. 1994, 76:681-688.
7. Calvet J.H., Gascard J.P., Delamanche S., Brink C. Airway epithelial damage and release of inflammatory mediators in human lung parenchyma after sulfur mustard exposure. Hum. Exp. Toxicol. 1999, 18:77-81.
8. Calvet J.H., Planus E., Rouet P., Pezet S., Levame M., Lafuma C., Harf A., D'Ortho M.P. Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am. J. Physiol. 1999, 276:L754-L762.
9. Chakrabarti S., Patel K.D. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp. Lung Res. 2005, 31:599-621.
10. Colvin M., Hait W.N. Alkylating agents and platinum antitumor compounds. Cancer Medicine 2010, 633-644. People's Medical Publishing House-USA, Shelton, CT. W.K. Hong, R.C. Bast, W.N. Hait, D.W. Kufe, R.E. Pollock, R.R. Weichselbaum, J.E. Holland, E. Frei (Eds.).
11. Crosby L.M., Waters C.M. Epithelial repair mechanisms in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L715-L731.
12. Dusenbery K.E., Peterson B.A., Bloomfield C.D. Chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for Hodgkin disease: fourteen-year follow-up results. Am. J. Hematol. 1988, 28:246-251.
13. Gao X., Ray R., Xiao Y., Ishida K., Ray P. Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm. Pharmacol. Ther. 2010, 23:97-106.
14. Ghanei M., Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal. Toxicol. 2007, 19:451-456.
15. Guignabert C., Taysse L., Calvet J.H., Planus E., Delamanche S., Galiacy S., d'Ortho M.P. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L67-L74.
16. Korkmaz A., Yaren H., Topal T., Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch. Toxicol. 2006, 80:662-670.
17. Kumar O., Sugendran K., Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem. Biol. Interact. 2001, 134:1-12.
18. Laskin D.L. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem. Res. Toxicol. 2009, 22:1376-1385.
19. Laskin D.L., Gardner C.R., Laskin J.D. Phagocytes. Comprehensive Toxicology 2010, 133-153. Elsevier, UK. D. Lawrence (Ed.).
20. Laskin J.D., Heck D.E., Laskin D.L. Nitric oxide pathways in toxic responses. General and Applied Toxicology 2010, 425-438. Wiley-Blackwell, UK. B. Ballantyne, T. Marrs, T. Syversen (Eds.).
21. Laskin, D.L., Sunil, V.R., Gardner, C.R., Laskin, J.D., 2011. Macrophages and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol. 51, 267-288.
22. Malaviya, R., Sunil, V., Cervelli, J., Anderson, D., Holmes, W., Conti, M., Gordon, R., Laskin, J., Laskin, D.L., 2010. Inflammatory effects of inhaled sulfur mustard in rat lungs. Toxicol. Appl. Pharmacol. 248, 89-99.
23. McClintock S.D., Till G.O., Smith M.G., Ward P.A. Protection from half-mustard-gas-induced acute lung injury in the rat. J. Appl. Toxicol. 2002, 22:257-262.
24. Nagase T., Moretto A., Ludwig M.S. Airway and tissue behavior during induced constriction in rats: intravenous vs. aerosol administration. J. Appl. Physiol. 1994, 76:830-838.
25. O'Neill H.C., White C.W., Veress L.A., Hendry-Hofer T.B., Loader J.E., Min E., Huang J., Rancourt R.C., Day B.J. Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide. Free Radic. Biol. Med. 2010, 48:1188-1196.
26. Ponticos M., Holmes A.M., Shi-wen X., Leoni P., Khan K., Rajkumar V.S., Hoyles R.K., Bou-Gharios G., Black C.M., Denton C.P., Abraham D.J., Leask A., Lindahl G.E. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. 2009, 60:2142-2155.
27. Radomska-Lesniewska D.M., Skopinska-Rozewska E., Jankowska-Steifer E., Sobiecka M., Sadowska A.M., Hevelke A., Malejczyk J. N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients. Pharmacol. Rep. 2010, 62:131-138.
28. Rolin S., Masereel B., Dogne J.M. Prostanoids as pharmacological targets in COPD and asthma. Eur. J. Pharmacol. 2006, 533:89-100.
29. Shakarjian M.P., Heck D.E., Gray J.P., Sinko P.J., Gordon M.K., Casillas R.P., Heindel N.D., Gerecke D.R., Laskin D.L., Laskin J.D. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol. Sci. 2010, 114:5-19.
30. Smith K.J., Hurst C.G., Moeller R.B., Skelton H.G., Sidell F.R. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J. Am. Acad. Dermatol. 1995, 32:765-776.
31. Stout R.D., Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 2004, 76:509-513.
32. Sunil V.R., Patel K.J., Shen J.L., Reimer D., Gow A.J., Laskin J.D., Laskin D.L. Role of reactive nitrogen species in vesicant-induced lung injury and altered lung functioning. The Toxicologist 2010, 114, 73 (A336).
33. Tall E.G., Bernstein A.M., Oliver N., Gray J.L., Masur S.K. TGF-beta-stimulated CTGF production is enhanced by collagen and associated with biogenesis of a novel 31kDa CTGF form in human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2010, 51:5002-5011.
34. Ucar M., Korkmaz A., Reiter R.J., Yaren H., Oter S., Kurt B., Topal T. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol. Lett. 2007, 173:124-131.
35. van Helden H.P., Kuijpers W.C., Diemel R.V. Asthma-like symptoms following intratracheal exposure of guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 2004, 16:537-548.
36. Wang G.Q., Xia Z.F. Tissue injury by hot fluid containing nitrogen mustard. Burns 2007, 33:923-926.
37. Wattana M., Bey T. Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat. Prehosp. Disaster Med. 2009, 24:19-29.
38. Weber W.M., Kracko D.A., Lehman M.R., Irvin C.M., Blair L.F., White R.K., Benson J.M., Grotendorst G.R., Cheng Y.S., McDonald J.D. Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injury. Toxicol. Mech. Methods 2010, 20:14-24.
39. Wigenstam E., Rocksen D., Ekstrand-Hammarstrom B., Bucht A. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal. Toxicol. 2009, 21:958-964.
40. Wormser U., Langenbach R., Peddada S., Sintov A., Brodsky B., Nyska A. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice. Toxicol. Appl. Pharmacol. 2004, 200:40-47.
41. Yaren H., Mollaoglu H., Kurt B., Korkmaz A., Oter S., Topal T., Karayilanoglu T. Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res. Vet. Sci. 2007, 83:116-122.